Teva Pharmaceutical Industries Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Teva Pharmaceutical Industries Limited with three other
pharmaceutical manufacturers in Middle East:
Saudi Pharmaceutical Industries & Medical Appliances Corporation
of Saudi Arabia
sales of 1.39 billion Saudi Riyals [US$369.41 million]
of which 115%
was Pharmaceutical and Medical Manufacturing),
Taro Pharmaceutical Industries Ltd
(3.32 billion Israel Shekels [US$912.00 million]
of which 100%
was Pharmaceutical Indust), and
Egypt International Pharmaceuticals
based in Egypt
(2.53 billion Egyptian Pounds [US$141.10 million]
of which 100%
Teva Pharmaceutical Industries Limited reported sales of 79.94 billion Israel Shekels (US$21.95 billion)
December of 2017.
decrease of 4.6%
versus 2016, when the company's sales were 83.76 billion Israel Shekels.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Teva Pharmaceutical Industries Limited had sales
of 78.12 billion Israel Shekels.
Contributing to the drop in overall sales was the 14.8% decline
in Specialty Medicines, from 33.17 billion Israel Shekels to 28.26 billion Israel Shekels.
There were also decreases in sales in
Generic Medicines (down 4.5% to 43.77 billion Israel Shekels)
However, these declines were partially offset by the increase in sales of
Other (up 66.9% to 7.91 billion Israel Shekels)